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Abstract
The recognition of cryptic small-molecular binding sites in protein structures is important for understanding off-target side
effects and for recognizing potential new indications for existing drugs. Current methods focus on the geometry and
detailed chemical interactions within putative binding pockets, but may not recognize distant similarities where dynamics
or modified interactions allow one ligand to bind apparently divergent binding pockets. In this paper, we introduce an
algorithm that seeks similar microenvironments within two binding sites, and assesses overall binding site similarity by the
presence of multiple shared microenvironments. The method has relatively weak geometric requirements (to allow for
conformational change or dynamics in both the ligand and the pocket) and uses multiple biophysical and biochemical
measures to characterize the microenvironments (to allow for diverse modes of ligand binding). We term the algorithm
PocketFEATURE, since it focuses on pockets using the FEATURE system for characterizing microenvironments. We validate
PocketFEATURE first by showing that it can better discriminate sites that bind similar ligands from those that do not, and by
showing that we can recognize FAD-binding sites on a proteome scale with Area Under the Curve (AUC) of 92%. We then
apply PocketFEATURE to evolutionarily distant kinases, for which the method recognizes several proven distant
relationships, and predicts unexpected shared ligand binding. Using experimental data from ChEMBL and Ambit, we show
that at high significance level, 40 kinase pairs are predicted to share ligands. Some of these pairs offer new opportunities for
inhibiting two proteins in a single pathway.
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Introduction
Structural biology studies have provided large numbers of high-
resolution proteins, often bound to small molecule ligands. The
ability to predict additional ligands that will bind these proteins is
an exciting opportunity for understanding drug action and
repurposing. In some cases, the binding of a small molecule to a
protein may explain otherwise unexpected effects of the small
molecule, such as side effects of drugs. In other cases, the binding
of a small molecule may suggest new uses of existing drugs, based
on unexpected affinity to new targets.
Previous methods for predicting the potential binding of small
molecules to protein pockets have used evolutionary, structural,
biochemical and geometric properties in order to assess pocket
similarity, or ligand-pocket complementarity [1,2,3,4,5]. For
example, the method of sequence order-independent profile-
profile alignment (SOIPPA) [6] can recognize binding site
similarity between the cholesteryl ester transfer protein (CETP)
and off-targets, including retinoid X receptor and peroxisome
proliferator-activated receptors (PPARs). These new targets may
explain adverse drug effects of CETP inhibitors [7]. SOIPPA
represents binding sites with a tessellation of C-alpha atoms and
characterizes binding sites using geometric similarity potentials.
SOIPPA evaluates 3D alignments between binding sites that are
enriched for similar angles and distances between residues. It then
gauges overall similarity based on geometric criteria, evolutionary
and biochemical properties.
Like SOIPPA, other methods for locally comparing binding
sites typically have three steps [5]: (1) representation of binding
sites, (2) 3D alignment between two sites and (3) evaluation of a
similarity metric to the two sites. Searching for the best 3D
alignment is the essential step. There are geometric hashing
methods (SiteEngine [8] and SiteBase [1]) and methods based on
clique detection (SOIPPA [6], CavBase [9] and eF-site [10]).
These methods use thresholds to control the similarity of local
geometries in both types of methods, but these can be difficult to
set. In particular, flexible matching can be critical in achieving
high performance [11]. Thornton et al showed that binding sites
with similar ligands display greater conformational variability than
the corresponding ligand molecules [12]. Thus, using predefined
geometric models and thresholds is not optimal. Excessive reliance
on crystallographic poses for both the protein and the ligand can
miss potential similarities.
We have previously described the FEATURE methods for
describing active sites [13]. In the FEATURE representation, a
protein site is represented by one or more microenvironments—
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secondary structures as well as biochemical and biophysical
properties in radial shells around a central point [14]. We have
shown that the FEATURE representation is useful for describing
sites for Ca++ binding [14], Mg++ binding [15], serine protease
active sites [13], thioredoxin active sites [16] and others [17]. We
have also used it to evaluate the ability of engineered loops to bind
ligands [18]. In this work, we reasoned that the interactions
between microenvironments in the target protein and chemical
fragments in the ligand may drive molecular recognition. Because
the conformational arrangement of fragments within flexible
ligand molecules can be very different, we allow the corresponding
microenvironments to adopt different relative geometries. We
develop an algorithm, PocketFEATURE, to match microenviron-
ments within pockets in order to find pockets with potentially
similar binding capabilities.
We validate PocketFEATURE by testing its performance on
two tasks. First, we test its ability to detect the similarity of binding
sites that are known to bind the same (containing adenine-ribose)
ligands–a test of sensitivity. Second, we test its ability to detect
FAD binding across a large proteome-scale set of proteins–a test of
specificity. In both tests, the method shows very strong
performance, including an ability to detect similarities missed by
other methods.
Kinases play an important role in cell signaling, and can be
dysregulated in cancer. Several recently introduced cancer drugs
act as ATP analogues and inhibit kinase action [19,20]. Therefore,
the binding capabilities (or binding profiles) of kinases may be
useful for discovering novel kinase inhibitors. In particular, kinase
inhibitors that bind two or more kinases in the same pathway are
attractive because they can more effectively interfere with the
pathway, without the need for very high doses or multiple drugs
[21,22]. Kinase binding profiles may also be useful for under-
standing side effects of drugs that bind multiple proteins [22]. In
principle, the ability of an inhibitor to bind multiple kinases may
occur despite very low sequence and structure homology. For
these reasons, the ability to detect similar binding sites in divergent
kinases is potentially valuable.
There are sixteen cancer drugs approved or in advanced
development that are known to have multiple targets [22]. All of
these drugs target members of the same protein family that
regulate the same signaling process. Accordingly, most studies
have focused on dissecting the detailed binding preferences of
drugs on a relatively small set of kinases that are known to be
important. In fact, multi-target drugs that work on proteins within
distant families are only rarely reported [23]. Therefore, one of the
goals of this work is to discover unrecognized binding similarities
between remotely related proteins to increase the repertoire of
kinase inhibitor action and utility. Accordingly, we apply
PocketFEATURE to predict the similarity in inhibitor-binding
profiles between kinases. In particular, we seek similar inhibitor-
binding profiles for kinases that are evolutionarily distant.
Results
Detecting binding site similarity
We first validated PocketFEATURE’s ability to detect binding
site similarity. In particular, we tested its ability to recognize
pockets that bind similar ligands, and distinguish them from
pockets that do not bind these ligands. The benchmark dataset is
provided by Bourne group from USCD [6]. The ligands sharing
similarity are: ATP, ADP, NAD, FAD, SAH and SAM, all of
which contain an adenine-ribose moiety. We compared the
performance of PocketFEATURE to SOIPPA, which outperforms
other ligand-binding site comparison algorithms in this task [6].
Figure 1 shows PocketFEATURE’s ability to recognize 30381
pairs of sites that both bind adenine-ribose moieties, and to
recognize the lack of similarity of 24947 control pairs of sites in
which one site binds adenine-ribose and the other does not. The
AUC for the entire benchmark is 0.85. At specificities of 95% to
99.5%, PocketFEATURE outperforms SOIPPA. At 95% speci-
ficity, PocketFEATURE identifies about 40% similar pairs, while
SOIPPA identifies less than 30%. Our results demonstrate that
PocketFEATURE can identify binding sites with overlapping
chemical specificity. Proteins in this test are evolutionarily
divergent (,5% of them are from the same SCOP superfamily).
Thus, PocketFEATURE can detect site similarity across remote
evolutionary relationships.
Figure 2 shows an ATP-binding site (1kvk), an NAD-binding
site (1a5z) and an FAD-binding site (2b9w). There are five
corresponding microenvironments in each protein (spheres are
shown in Figure 2A and the types of microenvironments are listed
in Figure 2B). These five microenviroments are in proximity to the
adenine moiety from ATP, NAD and FAD molecules. It is
important to note that the five microenvironments adopt different
relative geometries in these three sample sites while coordinating
the ligands. We consider the five microenvironments to constitute
modules capable of recognizing adenine-ribose moieties contained
within diverse ligand molecules.
The S(Tc) score captures the similarity of a pair of FEATURE
microenvironments. To evaluate the significance of alignments
between microenvironments, we calculated the probability
distribution function (PDF) of microenvironment similarity score
S(Tc) using a non-redundant dataset of 3D structures in PDB.
Given each set of the mutual alignment between ATP, NAD and
FAD binding sites, Figure 2C maps the three S(Tc) scores to the
corresponding microenvironment types. The alignments of high
significance form the basis for recognizing similarity between
binding sites detected by PocketFEATURE.
Detecting FAD-binding sites in a large druggable
database
The previous test demonstrated that PocketFEATURE can
sensitively detect similarities between adenine-ribose containing
pockets. We tested PocketFEATURE’s ability to specifically
Author Summary
Small molecule drugs may interact with many proteins.
Some of these interactions may cause unexpected effects,
including side effects or potentially useful therapeutic
effects. One way to predict these effects is to analyze the
three-dimensional structure of target proteins, and identify
new binding sites for small molecule drugs. Several
methods have been proposed for predicting new binding
sites, relying on geometric and functional complementar-
ity of the sites and the small molecules. In this paper, we
report on a new method for identifying novel protein-drug
interactions by analyzing the similarity between binding
sites in proteins. The method has relatively weak
geometric requirements and allows for conformational
change or dynamics in both the ligand and protein. Our
results show that geometric flexibility is useful for
effectively comparing sites. We have applied the method
to evolutionarily distant kinases, and find unexpected
shared inhibitor binding. Our results may be valuable for
drug repurposing in order to find novel uses for existing
kinase inhibitors.
Compare Ligand-Binding Sites
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Dataset-6958 is derived from an annotated database of ‘‘druggable
binding sites’’ from PDB called scPDB (see Method section). It
includes a total of 6709 non-FAD-binding proteins and 249 FAD-
binding proteins, from 43 EC-families. Using a single arbitrarily
selected FAD-binding site (1nhp/FAD) as a query structure, we
searched the database for all other FAD-binding sites from
Dataset-6958 by pairwise comparison. Figure 3A shows the overall
performance with an AUC value of 0.92. At 95% specificity,
PocketFEATURE identifies about 65% sites that are known to
bind FAD. At 80% specificity, PocketFEATURE identifies nearly
90% sites correctly.
Of note, FAD binds proteins in two general conformations [24]:
the (1) elongated and the (2) bent butterfly conformation
(Figure 3B). In the bent conformation (1nhp in Figure 3B), the
AMP portion is folded back, placing the adenine and isoalloxazine
rings in close proximity, whereas in the elongated conformation
(1fdr in Figure 3B) the adenine ring is distant from the
isoalloxazine ring. Remarkably, PocketFEATURE can detect
bent butterfly FAD sites based on an elongated FAD query
structure. Conversely, using a binding site with a bent butterfly
FAD as a query structure, PocketFEATURE can detect elongated
FAD binding sties (Supplementary Material Figure S1).
Figure 3B and 3C show the microenvironment alignments
detected by PocketFEATURE. (See Method section, A microen-
vironment is named using the following convention: ‘‘m’’ followed
by ‘‘residue index’’ and ‘‘residue type’’, upon which the
microenvironment is centered. PDB identifier or gene name is
tagged when necessary.) The aligned microenvironments
m6L1nhp-m67L/1fdr (red), m250W/1nhp-m248W/1fdr (orange)
and m79I/1nhp-m68V/1fdr (yellow) are near the adenine moiety
of FAD in 1nhp and 1fdr, respectively. Aligned microenviron-
ments m132R/1nhp-m77P/1fdr (pink) and m12G/1nhp-m77P/
1fdr (green) are adjacent to phosphate chemical groups. Another
two sets of microenvironments m159Y/1nhp-m52Y/1fdr (cyan)
and m300T/1nhp-m53S/1fdr (wheat) are found near flavin
groups. As might be expected, the different conformations of
FAD molecules in the structures 1nhp and 1fdr lead to markedly
different geometric arrangements of these aligned microenviron-
ments. However, PocketFEATURE identifies these alignments
with high significance, demonstrating the robustness of the
algorithm.
Other related benchmarks
We have performed three independent experiments to test
PocketFEATURE’s ability to specifically recognize non-adenine
ligand binding sites. First, using a typical steroid-binding site (1A28
bound with progesterone) to detect all other steroid-binding sites
(total 83 sites) from Dataset-6985 (Supplementary Material Figure
S2). The overall AUC is 0.826. Second, we compared Pock-
etFEATURE to a 3D shape descriptor using real spherical
harmonic expansion coefficients [25,26]. Using their published
datasets (10 sites for ATP, 10 for NAD, 10 for heme and 10 for
steroids), PocketFEATURE successfully clusters the four types of
sites and compares favorably with the real spherical harmonic
shape descriptor (Supplementary Material Figure S3). Third, we
applied PocketFEATURE to predicted off-targets for Torcetrapib
from a non-redundant subset of PDB for 1200 human proteins.
Supplementary material Table S1 lists top ranked off-targets
predictions. Xie et al [7] published a panel of 20 off-targets for
CETP inhibitors (specifically Torcetrapib) predicted by SOIPPA.
These predictions have been refined and validated by docking
methods and critical human curation. Comparing the 20
published off-targets by SOIPPA and the 36 predictions by
PocketFEATURE, we find that seven are the same. These three
tests show that PocketFEATURE effectively recognizes non-
adenine ligand binding sites.
The Similarity Ensemble Approach (SEA) is a method for
calculating chemoinformatics similarities between drug sets [27].
Given two binding sites, we incorporate the similarity scores
between experimentally observed ligand molecules calculated by
SEA into the PocketFEATURE similarity score between the
Figure 1. Comparison of the performance of PocketFEATURE to SOIPPA. The benchmark measures the ability to discriminate 30381 pairs of
sites that both bind adenine-ribose moieties from 24947 control pairs of sites where one site binds adenine-ribose and the other does not. The AUC
for the entire benchmark is 0.85. At the specificity range of 95% to 99.5%, PocketFEATURE outperforms SOIPPA. At 95% specificity, PocketFEATURE
identifies about 40% positive pairs, while SOIPPA identifies less than 30%.
doi:10.1371/journal.pcbi.1002326.g001
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chemoinformatics and target physiochemical properties leads to
strong signals for similarity detection (Supplementary Material
Figure S4).
Predicting inhibitor-binding for distantly related kinases
Having established reasonable sensitivity and specificity of
PocketFEATURE, we studied ATP-binding sites in kinases, to find
new targets for these inhibitors. We specifically targeted kinase
proteins that are distantly related, with little detectable sequence or
structural similarity, because most previous work has focused on
the binding properties of closely related kinases.
We calculated the binding site similarity scores of the 6058 pairs
sites in distantly related kinases using PocketFEATURE. Figure 4
plots the PDF of the scores for the 6058 pairs. A small p-value
suggests an increased likelihood of high binding site similarity for
the pair of proteins evaluated.
CHEMBL is a manually curated chemical database of bioactive
molecules with drug-like properties [28]. Our local database
downloaded from CHEMBL includes binding assays between a
total of 3199 protein domains and 541,137 compounds. Similarly,
the Ambit panel provides high-throughput kinase selectivity
profiling of 317 kinases against 37 known kinase inhibitors [29].
Of the 6058 pairs we evaluated, there are 40 pairs for which
experimental data (from CHEMBL or Ambit) are available for
both kinases. Of these pairs, 11 had experimental results
suggesting high overlap in inhibitor binding—they are ‘‘positive-
pairs’’. When we rank order the 40 pairs based on their scores,
nine of the 11 positive-pairs rank first through eighth, and tenth
(Figure 4). The binding site similarity scores of negative-pairs
Figure 2. An example illustrating how PocketFEATURE identifies similar sites that bind to ligands with overlapping chemical
specificity. We compare an ATP-binding site (1kvk/ATP), an NAD-binding site (1a5z/NAD) and an FAD-binding site (2b9w/FAD). There are five sets of
mutual aligned microenvironments between the three sites. (A) 3D structures of the binding site. The five sets of mutual aligned microenvironments
are represented as colored spheres: red for microenvironment centered at residue type E(mE) or D (mD), blue for mT, green for mY, orange for mV or
mI and purple for mP. The five microenviroments are close to the adenine moiety from ATP, FAD and NAD molecules. The aligned
microenvironments display different relative geometries in the three sites. 3D illustrations were generated using PyMOL [37]. (B) Index of center
residues for the mutual aligned microenvironments. (C) Significance of alignments. Tc scores between the five sets of mutual aligned
microenvironments are mapped to the pre-calculated PDF for a given type of microenvironment pair. The scores between ATP-binding and NAD-
binding sites are marked using diamonds, those between ATP-binding and FAD-binding using circles, and those between NAD-binding and FAD-
binding using squares. For each of the five sets, the S(Tc) scores fall within the p-value cutoff of 0.05.
doi:10.1371/journal.pcbi.1002326.g002
Compare Ligand-Binding Sites
PLoS Computational Biology | www.ploscompbiol.org 4 December 2011 | Volume 7 | Issue 12 | e1002326Figure 3. Identification of FAD-binding sites in a large druggable database. (A) The overall performance with an AUC value of 0.92 At 95%
specificity, PocketFEATURE identified about 65% sites that are known to bind FAD. At 80% specificity, PocketFEATURE identified nearly 90% sites
correctly. (B) Microenvironment alignments between two FAD-binding sites. Two sites adapt to two different ligand conformations, an elongated
(1nhp) and a bent butterfly conformation (1fdr). The relative geometries arrangements of aligned microenvironments are different. (C) An illustration
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significance of the separation of positive-pairs and negative-pairs in
this ranking, as evaluated by a hyper-geometric distribution has a
p-value of 4.5e-18.
Using a p-value cutoff ,0.01 from the PDF (binding site
similarity score cutoff of 23.76 in Figure 4), 50 pairs of kinases are
predicted to have inhibiting-profile overlapping. Nine pairs have
experimental evidence suggesting overlap in inhibitor binding-
these are true positives (Table 1). One pair is considered false
positive because although the two kinases are tested in CHEMBL,
they do not share ligands using our relatively stringent cutoff
(Table 2). The other 40 pairs with high apparent similarity are
novel predictions (Table 3). Experimental evidence for these
kinases pairs is not available in CHEMBL or Ambit.
Discussion
We have presented a new algorithm for detecting ligand-
binding site similarity, tested it on (1) the recognition of adenine-
ribose binding ligands and (2) the recognition of FAD binding sites.
We then applied it to the problem of predicting cross binding of
ATP analogues inhibitors of kinases.
Summary of PocketFEATURE method
Our method works for two reasons. First, we employ a novel
microenviroment-based representation and scoring system for
comparing pockets that captures the physical and chemical
properties in the binding pocket, and second, we do not impose
rigid geometric matching criteria on the microenvironments
within the pocket. The resulting method accurately recognizes
similar microenvironments, and identifies combinations of micro-
environments that can interact with fragments within ligand
molecules.
Representation and similarity measure between
individual microenvironments. Microenvironments are
represented using the FEATURE representation that captures
physiochemical properties of a local subsite. The raw Tc score
measures similarity between two microenvironments. However, it
is difficult to compare Tc scores across pairs of microenvironments
because the background similarities between different pairs are not
the same. Therefore, it is necessary to normalize the Tc scores. We
normalize the scores by creating a background distribution for
each pair type (See Method). The normalized score S(Tc) is
negative, decreases monotonically with increasing Tc, and
changing most rapidly for Tc.Tc0. Therefore, our method
seeks microenvironment-pairs that have high similarity, given the
expected background score distribution.
We aligned microenvironments from an ATP, FAD and an
NAD binding site (Figure 2). Microenvironment similarity score
S(Tc) of aligned ones are outliers within the PDF (Figure 2C). The
aligned microenvironments constitute functional modules for
ligand recognition (Figure 2A). That is, particular microenviro-
ments are associated with the recognition of particular molecular
fragments with ligands. A better (more negative) S(Tc) similarity
captures this shared recognition role in different binding sites.
Geometric flexible matching between microenvi-
ronments. The combined interactions between multiple
microenvironments in a target protein and molecular fragments
within its ligand molecule drive molecular recognition. Because
fragments can adopt different poses within a ligand molecule, the
FEATURE based microenvironments in the target protein can
adopt different relative geometries, as shown in Figure 3C. Some
of the corresponding positioning of aligned microenvironments and FAD molecules. The aligned microenvironments m6L/1nhp-m67L/1fdr (red),
m250W/1nhp-m248W/1fdr (orange) and m79I/1nhp-m68V/1fdr (yellow) are near the adenine moiety of FAD molecules in 1nhp and 1fdr, respectively.
Near phosphate chemical groups, aligned m132R/1nhp-m77P/1fdr (pink) and m12G/1nhp-m77P/1fdr (green) are observed. Another two sets of
microenvironments m159Y/1nhp-m52Y/1fdr (cyan) and m300T/1nhp-m53S/1fdr (wheat) are found close to flavin groups.
doi:10.1371/journal.pcbi.1002326.g003
Figure 4. Predicting overlapping of inhibitor-binding profiles between kinases. The binding site similarity scores of 6058 pairs of distant
kinases were fitted into normal distribution. The more negative the score, the higher level of similarity between two sites is predicted. The blue
dotted line is the p-value cutoff of 0.01 for highly ranked predictions (Table 1). Of the 6058 pairs, there are 40 pairs of which experimental data are
available to both kinases. Out of the 40 pairs, 11 pairs have experimental results suggesting overlap in inhibitor binding – they are ‘‘positive-pairs’’.
The remaining 29 pairs are ‘‘negative-pairs’’ that do not share ligands. The significance of the separation of positive-pairs and negative-pairs in this
ranking, as evaluated by a hyper-geometric distribution has a p-value of 4.5e-18.
doi:10.1371/journal.pcbi.1002326.g004
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functionalmodules.PocketFEATUREhasrelativelyweakgeometric
requirements (only that the matching microenvironments be present
within the pocket of interest). As a result, the number of possible
alignments between pockets is increased, and PocketFEATURE can
recognize site that bind similar ligands in different poses.
Our results with FAD-binding sites illustrate the value of
geometric flexibility; FAD contains highly flexible regions between
flavin and adenine. The FAD conformation and orientation varies
widely across different protein families. By using PocketFEA-
TURE, microenvironments corresponding to the same fragments
within FAD are recognized even though these microenvironments
adopt different local geometries according to their ligand poses
(Figure 3C). These results demonstrate the value of allowing
microenvironments to adopt variable orientations within pockets.
We have also assessed whether the microenvironment align-
ments identified by PocketFEATURE correspond to specific
recognition of ligand chemical substructures. The average number
of microenvironments between two ATP sites is six; while that of
ADP is six, that of NAD is ten and that of FAD is twelve. The
common aligned microenvironments of high frequencies for these
four types of binding sites are: mD, mE, mR, mK, mS and mT, all
of which are in close proximity to the common sub-fragments
contained within ADP, ATP, FAD and NAD: the adenine, ribose
and phosphate. Thus, these microenvironments have specific roles
in recognizing particular fragments within the overall molecule.
Furthermore, the additional aligned microenvironments observed
in FAD and NAD sites are mW and mP, which ‘‘recognize’’ the
phosphate, flavin or nicotinamide moieties.
In summary, PocketFEATURE is more sensitive than other
state-of-the-art methods. It is suitable for application on a genome
scale.
PocketFEATURE defines sites based on position of known
ligand binding. For apo structures and uncharacterized sites, we
can also use published patch-searching algorithms, such as
CONCAVITY [30] and PocketPicker [2] to define sites (on-going
projects).
Application of PocketFEATURE to drug discovery
Current computational studies on comparing kinase inhibitor
binding sites often focus on known drug targets Tyrosine kinase
(TK family, EC 2.7.10) and Serine/Threonine kinases ISTE
family (EC 2.7.11). Potential similarity between divergent kinases
has not been systematically explored either computationally or
experimentally. For example, of the 6058 pairs of divergent
kinases we compared in this work, only 40 pairs have experimental
data from CHEMBL and Ambit. The literature is biased towards
a few well-validated kinases. Some inhibitors may appear to be
more promiscuous simply because they have been profiled more
systematically.
As shown in Figure 4, PocketFEATURE identifies similar
ligand binding sites across distantly related kinases. The surpris-
ingly accurate predictions (Table 1) for those that have been tested
make the remaining untested predictions (Table 3) with high
similarity scores particular interesting.
Some of our predictions rediscover combinations of divergent
kinases for multi-targeted drug design. One highly ranked
prediction is the pair SRC (a Tyrosine kinase) and PIK3CG (a
lipid kinase in PI3K family), which are evolutionarily distant
(PID,10%). Both kinases have been observed to bind to a similar
series of inhibitors (PP121 and its derivatives) [23]. The
PocketFEATURE binding site similarity score (24.26) ranks high
—20th out of 6058 pairs. PocketFEATURE identifies six key
microenvironments (Figure 5). One alignment matches mT338/
SRC to mY867/PIK3CG, both of which reside near the typical
‘‘gate’’ of an ATP-binding site. The gatekeeper residue enables
interactions between the deep hydrophobic pocket and ligands
(adenine in ATP or pyrazolopyrimidine in inhibitor ABJ). In SRC
structures, residue T338 is designated as the gatekeeper and in
PIK3CG structures, residue I879 [23]. As PocketFEATURE does
not seek alignments between polar and hydrophobic residues, it
Table 1. True positives predictions.
EC group PDB ID Gene name PID Binding sitesimilarity Representativeinhibitor
2.7.10.2 2.7.11.22 2src 3blq SRC CCNT1 10. 24 25.85 AST-487
2.7.10.1 2.7.11.26 2hen 1j1c Ephb2 GSK3B 25.63 25.31 CHEMBL247067
2.7.10.1 2.7.11.26 1jqh 1j1c IGF1R GSK3B 27.86 24.34 CHEMBL215803
2.7.10.1 2.7.11.22 2hen 2cch Ephb2 CDK2 19.98 24.30 AST-487
2.7.1.153 2.7.10.2 1e8x 2src PIK3CG SRC 18.26 24.28 PP121
2.7.10.1 2.7.11.22 1jqh 2cch IGF1R CDK2 23.94 24.25 BMS-536924
2.7.10.1 2.7.11.24 2hen 1cm8 Ephb2 MAPK12 26.61 24.15 AST-487
2.7.10.1 2.7.11.24 1jqh 1cm8 IGF1R MAPK12 29.36 23.83 CHEMBL215803
2.7.1.153 2.7.11.1 1e8x 2pvr PIK3CG CSNK2A1 23.17 23.80 CHEMBL379156
Using a p-value cutoff of 0.01, 50 pairs of kinases are predicted to share inhibitors. Nine pairs have experimental evidence suggesting overlap in inhibitor binding- these
are true positives. The first two columns are EC groups. Kinases in one pair are from different EC groups. The PDB IDs and gene names are listed in column three to
row six. The seventh column lists the percentage identity (PID) of structural alignment between two kinases in a pair. The eighth column shows the binding site
similarity score of the pair. The more negative the score is, the higher the similarity level between two sites is predicted.
doi:10.1371/journal.pcbi.1002326.t001
Table 2. False positive predictions.
EC group PDB ID Gene name PID
Binding site
similarity
2.7.1.153 2.7.12.2 1e8x 1s9j PIK3CG MAP2K1 28.37 23.88
One pair is considered false positive because both kinases are linked to at least
one set of experimental data from CHEMBL, but they do not share ligands using
our stringent standards.
doi:10.1371/journal.pcbi.1002326.t002
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PIK3CG. Instead, in the PIK3CG structure, the proximal
mY867/PIK3CG is aligned to mT338/SRC. Thus, PocketFEA-
TURE detects similar binding sites from these two distant kinases.
SRC activates the lipid kinases of the PI3K family, a central
regulator of cell growth. Molecules that target both SRC and
PIK3CG may have potent antitumor activity.
PIK3CG is also predicted to share ligands with other kinases,
including CSNK21A, MAP2K1, GCN2 and ACK2 (Table 1–3).
Of these, CSNK21A encodes a Casein kinase that is involved in
Wnt signaling pathway. Casein kinase inhibitors are considered
potent anti-cancer drug candidates [31]. It is possible that drugs
inhibiting both CSNK21A and PIK3CG may have synergistic
anti-tumor activity. ACK2 is a homolog of CSNK21A
Table 3. Novel predictions of high similarity.
EC group PDB ID Gene name PID Binding sitesimilarity
2.7.11.2 2.7.13.3 2e0a 3d36 PDK4 spo0ANE 28.54 26.6061
2.7.11.2 2.7.13.3 1jm6 3d36 Pdk2 spo0ANE 28.75 25.4505
2.7.1.95 2.7.11.1 1j7u 1zp9 aphA rio1 12.55 25.4243
2.7.11.1 2.7.13.3 1th8 2c2a spoIIAB TM_0853 12.5 25.2046
2.7.1.100 2.7.11.1 2pyw 1csn At1g49820 cki1 28.33 24.9383
2.7.1.100 2.7.11.1 2olc 1zp9 mtnK rio1 10.24 24.6189
2.7.1.100 2.7.11.1 2pyw 1u5r At1g49820 Taok2 10.71 24.475
2.7.1.100 2.7.11.24 2olc 1cm8 mtnK MAPK12 10.55 24.4283
2.7.1.153 2.7.11.1 1e8x 1zyd PIK3CG GCN2 11.09 24.4036
2.7.10.2 2.7.11.1 2ijm 1zp9 PTK2 rio1 25.91 24.4022
2.7.10.1 2.7.11.1 1mqb 1zp9 EPHA2 rio1 25.76 24.3987
2.7.1.100 2.7.11.1 2olc 1zyd mtnK GCN2 13.19 24.3499
2.7.1.100 2.7.11.1 2pyw 3e7e At1g49820 BUB1 28.83 24.3048
2.7.1.153 2.7.11.1 1e8x 1lp4 PIK3CG ACK2 23.24 24.2874
2.7.1.100 2.7.11.1 2olc 3e7e mtnK BUB1 25.83 24.2698
2.7.1.95 2.7.11.1 1j7u 3e7e aphA BUB1 7.21 24.2628
2.7.1.100 2.7.11.26 2pyw 1j1c At1g49820 GSK3B 12.26 24.1925
2.7.1.100 2.7.12.2 2pyw 1s9j At1g49820 MAP2K1 27.68 24.1752
2.7.10.1 2.7.11.1 2hen 1q97 Ephb2 SKY1 21.35 24.1734
2.7.1.100 2.7.10.2 2olc 2ozo mtnK ZAP70 12.66 24.1549
2.7.1.36 2.7.12.2 1kvk 1s9j Mvk MAP2K1 11.07 24.1171
2.7.10.1 2.7.11.1 1jqh 2vwi IGF1R OXSR1 24.17 24.1001
2.7.1.100 2.7.11.24 2pyw 1cm8 At1g49820 MAPK12 10.86 24.0862
2.7.10.1 2.7.11.1 1pkg 1zp9 KIT rio1 24.51 24.077
2.7.1.100 2.7.11.1 2pyw 1o6l At1g49820 AKT2 29.75 24.0536
2.7.1.100 2.7.10.2 2pyw 2src At1g49820 SRC 20.49 24.0529
2.7.1.- 2.7.11.1 2a19 1zp9 SUI2 rio1 20.29 24.0507
2.7.1.100 2.7.11.1 2pyw 1zyd At1g49820 GCN2 13.19 24.0412
2.7.10.1 2.7.11.1 2hen 1zp9 Ephb2 rio1 14.78 24.0407
2.7.10.2 2.7.11.1 2src 1zp9 SRC rio1 24.28 24.0122
2.7.1.95 2.7.11.1 1j7u 1tqp aphA rio2 14.83 24.0018
2.7.1.100 2.7.11.1 2olc 1u5r mtnK Taok2 12.82 23.9498
2.7.1.95 2.7.11.1 1j7u 1u5r aphA Taok2 19.01 23.9436
2.7.1.100 2.7.10.1 2pyw 1pkg At1g49820 KIT 17.11 23.9048
2.7.11.4 2.7.4.22 1gkz 2bri Bckdk pyrH 11.08 23.8977
2.7.1.100 2.7.12.2 2olc 1s9j mtnK MAP2K1 27.68 23.8804
2.7.1.95 2.7.11.24 1j7u 1cm8 aphA MAPK12 11.79 23.8187
2.7.1.36 2.7.10.1 1kvk 2qoc Mvk EPHA3 10.6 23.8101
2.7.1.100 2.7.10.2 2pyw 2ozo At1g49820 ZAP70 15.23 23.8093
2.7.1.144 2.7.11.1 2f02 1u5r lacC Taok2 7.63 23.8036
In the top 50 ranked predictions, there are 40 pairs of novel predictions that experimental evidence for one for both kinases is not available in CHEMBL or Ambit.
doi:10.1371/journal.pcbi.1002326.t003
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PLoS Computational Biology | www.ploscompbiol.org 8 December 2011 | Volume 7 | Issue 12 | e1002326Figure 5. An example of validated positive predictions. SRC (a Tyrosine kinase) and PIK3CG (a lipid kinase) bind to a same series of inhibitors
(PP121 and its derivatives). Four related structures are available in PDB. The first row is structures of SRC bound with ANP (PDB ID: 2src) and a drug-
like inhibitor (PDB ID is 3en7 and ligand PDB code is ABJ). The second row is structures of PIK3CG bound with ATP (PDB ID is1e8x) and ABJ (PDB ID is
2v4l). Between binding sites of 2src (SRC/ANP) and 1e8x (PIK3CG/ATP), PocketFEATURE aligned six pairs of microenvironments. At the position near
the typical ‘‘gate’’ of an ATP-binding site, PocketFEATURE aligned mT338/SRC to mY867/PIK3CG (light yellow sphere). In SRC structures, the
gatekeeper residue T338 enables interactions between the deep hydrophobic pocket and ligands. The original experimental study suggests the
residue analogous to the gatekeeper in PIK3CG is I879 (red circle), which is the nearest microenvironment to mY867/PIK3CG. (A). 3D illustration of
binding sites in SRC and PIK3CG (B). Aligned microenvironments.
doi:10.1371/journal.pcbi.1002326.g005
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and ACK2 ranks highly—18th out of 6058 pairs.
In addition to its similarity to CSNK21A, the pocket in
PIK3CG is very similar to that in MAP2K1. These proteins do not
share known ligands using our stringent interpretation of
CHEMBL results (see Method). However, this apparent false
positive deserves further scrutiny. MAP2K1 encodes an essential
kinase in mitogen-activated protein (MAP) kinase signal transduc-
tion pathway. Activation of MAP kinase pathway plays important
roles in the metastasis of pancreatic cancer. Specific inhibitors
have been developed to inhibit oncogenic pathways. However,
activation of PI3K pathway in response to MAP2K1 inhibition
through a negative feed back loop limits the efficacy [32]. The
high similarity between PIK3CG and MAP2K1 by PocketFEA-
TURE suggest the possibility of inhibitors that target both kinases.
Other highly ranked novel predictions have some implications
for side effects and drug repurposing. In Table 3, there are three
pairs of mammalian: {Mvk-MAP2K1}, {Mvk-EPHA3} and
{1GF1R-OXSR1}. Of these kinases, MAP2K1, OXSR1 and
EPHA3 are implicated in cancer. Further evaluation of these pairs
may be warranted. Most of other pairs in Table 3 are
combinations of one kinase from human (or other mammalian)
and one from plant (or bacteria). It is intriguing to consider that
inhibitors for plant or bacterial kinases may be useful inhibitors of
mammalian proteins.
Methods
FEATURE microenvironments
Given a functional center of a residue, we use the term
‘‘microenvironment’’ to refer to the local, spherical region in the
protein structure that may encompass residues discontinuous in
sequence and structure. Specifically, we use the FEATURE system
to calculate a set of 80 physicochemical properties (Table S2) [14]
collected over six concentric spherical shells (total 480 proper-
ties=80 properties66 shells) centered on the predefined functional
center (Table S3) [33]. The total radius of the microenvironment is
7.5 Angstroms. A microenvironment is named using the following
convention: ‘‘m’’ followed by ‘‘residue index’’ and ‘‘residue type’’,
upon which the microenvironment is centered. PDB identifier or
gene name is tagged when necessary. For example m6L/1nhp
represents the microenvironment centered on the functional center
of the sixth residue in 1nhp, which is leucine (L). A complete
description of FEATURE can be found in the original publication.
Similarity measure between two FEATURE
microenvironments
Given a pair of FEATURE microenvironments (A and B)
derived from two different sites, we calculate an adjusted
Tanimoto coefficient based on the presence/absence of similar
properties. We compute a single standard deviation (STD) for
each of the 480 properties across a random set of FEATURE
microenvironments (see section ‘‘Background calculation). Two
microenvironments have a ‘‘similar property’’ if they differ by less
than one STD for the given property. Given A and B, c is the
number of ‘‘similar properties’’; a and b are the numbers of non-
zero properties in A and B, respectively; the denominator is the
total number of unique properties that are non-zero in A or B or
both (a+b2c); then the Tanimoto similarity is as follows:
Tc~
c
azb{c
.
Background calculation
We make observations of the background distributions of Tc
scores between microenvironments from different sites. We
compile a dataset of 1160 sites from a non-redundant set of 3D
structures in PDB using these filters: (1) structures were solved
using X-ray diffraction at resolutions higher than 2.0 Angstrom; (2)
no two structures have greater than 40% sequence identity; (3)
specifically bound small molecule ligands have more than the
heavy atoms. The binding residues are defined as those having any
atom within 6 Angstroms of the ligand molecules, resulting in a
total of 22008 microenvironments. There are 242 possible types of
pairs between 22 types of microenvironments centered on 20
residues types (two centers for residue W and Y), but not all of
these are likely to be matched. For computational efficiency, we
group residues by physical properties in order to avoid
comparisons that are unlikely to yield high similarity scores. The
comparisons are limited to pairs of microenvironments that fall
within the same groups: positively charged (R H K), negatively
charged (D E), polar (S T Q N W1 Y1), non-polar (A C G I L M P
V) and aromatic (W2 Y2 F). This produces 72 microenvironment-
pairs (out of the 200 possible) that we check for high similarity
scores. Given each microenvironment-pair, we derive Tc scores
from the above dataset and fit these score into normal distribution.
Comparing two binding sites
Given the FEATURE microenvironments from two binding
sites, we exhaustively calculate the raw Tc scores of all permissible
microenvironment-pairs. We then normalize the Tc scores using
the background frequency [34]:
S(Tc)~
2
1z(Tc=Tc0)
2 {1
Tc0 is the value at which S(Tc) is zero.
In practice, Tc0 is the Tc score at the mode on the fitted
cumulative distribution function (CDF) of a given type of
microenvironment-pair (See Background calculation). The nor-
malized value, S(Tc), measures the similarity between two
microenvironments and is thus the microenvironment simi-
larity score.
We search for the mutual best-scoring microenvironment-pairs
between two binding sites and assign alignment to such pairs using
an cutoff of S(Tc) less than 20.3. For example, between site A
(microenvironments A1, A2, A3, A4 and A5) and site B
(microenvironments B1, B2, B3, B4 and B5), we align A1 to B1
only when (1) S(Tc) between A1 and B1 is smaller than those
between A1 and B1, B2, B4 B5, also smaller than those between
B1 and A2, A3, A4, A5; (2) S(Tc) between A1 and B1 is smaller
than 20.3. The sum of all aligned microenvironment-pairs is the
overall similarity score between two binding sites, and is termed
the binding site similarity score. We can vary the cutoff for S(Tc) to
change the precision and resolution of the comparison.
Benchmark datasets
We perform two sets of benchmark. The first benchmark
identifies pairs of proteins that bind adenine-containing ligands,
using two datasets [6] provided by Bourne group from USCD.
Dataset I consists of 247 sites from non-redundant protein
structures known to bind an adenine-containing ligand (ATP,
ADP, NAD, FAD, SAH and SAM); Dataset II consists of 101
cavities from non-redundant protein structures believed not to
bind an adenine-containing moiety. From Dataset I, we have
30381 pairs of sites that both bind adenine-containing ligands.
Between Dataset I and II, we have 24947 control pairs of sites in
which one site binds adenine-containing ligands and the other
does not.
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large-scale dataset. A dataset consisting of 6958 druggable binding
sites (Dataset-6958) was derived from scPDB entries [35] by
filtering out PDB entries where atom coordinates of binding
residues were incomplete. The binding sites were defined by
including all the protein residues with at least one atom within 6
Angstrom of any ligand atom. Dataset-6958 includes a total of 249
FAD-binding proteins.
Predicting inhibitor-binding profiles of kinases
We derive a subset of 984 binding sites from Dataset-6958,
including proteins classified in eight different EC families: EC
2.7.1, EC 2.7.2, EC 2.7.3, EC 2.7.4, EC 2.7.10, EC 2.7.11, EC
2.7.12 and EC 2.7.13. A total of 203 sites bind to ATP, ANP or
ADP. The other 781 structures bind to 633 other ligands.
Using the 203 sites involved in binding ATP, ANP or ADP, we
generate pairs of binding sites from functionally and structurally
distant kinases by applying two rules: (1) two kinases are from
different EC sub-subgroups; (2) the identity of structural alignment
by MAMMOTH [36] between the two kinases is not higher than
30%. This results in 6058 pairs of sites that bind to ATP, ANP or
ADP.
We perform validation using experimental data from CHEMBL
[28] and Ambit panel [29]. Ambit panel contains binding assays
between 37 inhibitors (21 tyrosine kinase inhibitors, 15 serine-
threonine kinase inhibitors, and 1 lipid kinase inhibitor), which are
classified according to the targets for which they were originally
developed, and 317 human kinases (287 different human protein
kinases, three lipid kinases and 27 disease-relevant mutant
variants). Staurosporine is a non-selective kinase inhibitor and is
therefore removed from the validation dataset.
We use two standards to identify candidate inhibitors from
Ambit panel: a stringent cutoff of Kd,1 uM and a ratio of off-
target to primary target affinities (Kd off-target/Kd primary
target) ,100. Our local database downloaded from CHEMBL
includes binding assays between 3199 protein domains and
541,137 compounds. It is a collection of assays from a variety of
experimental studies and therefore the standards applied to Ambit
Panel are not applicable to CHEMBL data. We first filter out data
with confidence level less than seven. We then use either (1) a
cutoff of IC50 less than 1 uM or (2) a cutoff of Kd less than 1 uM
or (3) inhibition level higher than 90% at 1 uM as an indication of
inhibition.
From the 6058 pairs of divergent kinases, we first search for
pairs for which experimental data, from CHEMBL or Ambit, are
available for both kinases. Given such a pair, if at least one
compound/inhibitor satisfies the standards above for both kinases,
the pair shares ligand binding and is a ‘‘positive-pair’’; otherwise
this pair is a ‘‘negative-pair’’.
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